SRNE Stock Ownership Activity

SORRENTO THERAPEUTICS INC 13F holders

No value investing guru has made any change to the SORRENTO THERAPEUTICS INC (SRNE) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying SRNE now?

According to the latest SEC filing(s) SORRENTO THERAPEUTICS INC (SRNE) has not been purchased by any super investor.

To see more about who is investing in SORRENTO THERAPEUTICS INC (SRNE), please go to the SRNE ownership page.

2023 Q2 (1 result)
Howard Marks
-100.00%
-109,210
-0.00%
0.00%
Current price: $0.02 94.44% Reported price*: $0.36
2022 Q2 (1 result)
Howard Marks
-10.67%
-8,160
-0.00%
0.00%
Current price: $0.02 99.00% Reported price*: $2.01
2021 Q4 (1 result)
Howard Marks
+11.94%
+16,000
+0.00%
0.01%
Current price: $0.02 99.57% Reported price*: $4.65
2021 Q2 (1 result)
Howard Marks
-58.13%
-112,530
-0.03%
0.01%
Current price: $0.02 99.79% Reported price*: $9.68
2021 Q1 (1 result)
Howard Marks
buy
+176,000
+0.04%
0.02%
Current price: $0.02 99.76% Reported price*: $8.27
2020 Q3 (1 result)
Howard Marks
-100.00%
-88,942
-0.02%
0.00%
Current price: $0.02 99.68% Reported price*: $6.28
2020 Q2 (1 result)
Howard Marks
buy
+88,942
+0.02%
0.00%
Current price: $0.02 99.68% Reported price*: $6.28
7 of 7

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.